ENZN
Enzon Pharmaceuticals, Inc. [ENZN] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ENZN Stock Summary
Top 10 Correlated Stocks
ENZN
In the News
ENZN Financial details
Company Rating
-
Market Cap
7.04M
Income
1.37M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
06 May 2024
P/E
7.27
Forward P/E
-
PEG
-0.48
P/S
289.15
P/B
2.99
P/C
-
P/FCF
7.67
Quick Ratio
114.67
Current Ratio
115.48
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0
EPS next Y
-
EPS next Q
-
EPS this Y
-840%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-575%
-
-
-
-
SMA20
-18.18%
SMA50
-40%
SMA100
12.5%
Inst Own
-
Inst Trans
-
ROA
2%
ROE
3%
ROC
-0.02%
Gross Margin
100%
Oper. Margin
-3996%
Profit Margin
3977%
Payout
123%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.06-0.23
52W High
-
52W Low
-
RSI
46.25
Rel Volume
0.02
Avg Volume
17.67K
Volume
400
Perf Week
-4.94%
Perf Month
-6.27%
Perf Quarter
14.18%
Perf Half Y
17.75%
-
-
-
-
Beta
0.327
-
-
Volatility
0.01%, 0.01%
Prev Close
4.67%
Price
0.0942
Change
4.67%
Company Profile
- Volume Average 17.67K
- Market Capitalization 7.04M
- CEO Mr. Richard L. Feinstein
- Headquarters Cranford,NJ,US
- IPO Date 1984-02-15
-
Website
https://www.enzon.com 
Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.
